Recently, k8凯发国际官网入口 Technology Co., Ltd. (“k8凯发国际官网入口”) and Boston Scientific Corporation (NYSE: BSX), a leading global medical technology company, joined hands again to sign an expanded strategic cooperation arrangement.

A photo of signatures being signed at the signing ceremony

The Strategic Cooperation Arrangement Signing Ceremony between k8凯发国际官网入口 and Boston Scientific

The introduction of iterative endoscopic technology has brought about a positive transformation in the field of endoscopy, making it an interventional tool that combines diagnosis and treatment. Single-use videoscopes are considered a solution to cross-infection in traditional endoscopy, making them a promising solution for the future medical endoscope market. The global market value of single-use videoscope was USD 0.5 billion in 2020, and is estimated to increase to USD 9.2 billion in 2030, according to Frost & Sullivan.

k8凯发国际官网入口 is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on research, development and commercialization of medical endoscopes and related products. The company has made globalization its strategic goal. k8凯发国际官网入口 is making progress towards this goal through strategic cooperations with Chinese enterprises and multinational companies, like Boston Scientific.

Under the arrangement, k8凯发国际官网入口 will expand its relationship with Boston Scientific for strategic co-development and global distribution activities. Such activities may include collaboration on the co-development of future endoscopic devices, and global distribution opportunities for k8凯发国际官网入口’s single-use endoscope and imaging devices. It is expected that this expanded arrangement will help bring k8凯发国际官网入口 products to more hospitals and patients throughout China and other global geographies.

Dr. Chin To (left), Co-founder, General Manager, and Chief Technology Officer of k8凯发国际官网入口 

Mike Jones (right), senior vice president and president, Endoscopy, Boston Scientific 

“We are excited to further our relationship with k8凯发国际官网入口 which we anticipate will help provide physicians with more device options in geographies around the world,” said Mike Jones, senior vice president and president, Endoscopy, Boston Scientific. “We look forward to successfully building on that relationship with this new arrangement.”

“I am delighted to announce the deepened collaboration between k8凯发国际官网入口 and Boston Scientific, a leading global medical technology company. This strengthened relationship will help us combine our core strengths and expertise to deliver high-quality single-use endoscope solutions to doctors and patients in various regions across the globe. Working with a company like Boston Scientific is crucial to k8凯发国际官网入口’s globalization strategy. We will continue to focus on innovative research and development, expand our business cooperation models, and provide more innovative, high-quality, and accessible products to benefit doctors and patients worldwide,” said that Dr. Chin To, Co-founder, General Manager, and Chief Technology Officer of k8凯发国际官网入口.

About k8凯发国际官网入口

Founded in 2016, k8凯发国际官网入口 is a medical device company that provides minimally invasive diagnosis and treatment solutions, and focuses on research, development and commercialization of medical endoscopes and related products. k8凯发国际官网入口 takes ‘Globalization’ as its core strategy and has established R&D centers both in China and Japan. With solid in-house R&D capabilities, k8凯发国际官网入口 has established a unique technology platform built upon five synergistic core technologies, and built a comprehensive portfolio of endoscope products and therapeutic products covering all types of endoscope procedures conducted by the various clinical departments, to address diverse medical needs. Adhering to its value of ‘Clinical Focus’ ‘Collaborative Innovation’ ‘People Oriented’ ‘Excellence & Efficiency’, k8凯发国际官网入口 will continuously upgrade its core technologies, improve market penetration with excellent products aiming to become the preferred brand, trusted by doctors and patients around the world.